Avalo Therapeutics (AVTX) Gross Margin (2017 - 2024)
Avalo Therapeutics' Gross Margin came in at -186.75% for Q3 2024, down 182.09 percentage points from -4.66% a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Gross Margin (2017 - 2024) Analysis & Trends
Over the trailing twelve months to Sep 30, 2024, Avalo Therapeutics reported Gross Margin of -11.71%, down 17.22 percentage points year-over-year; for FY2023, it came in at 33.26%, down 47.71 percentage points from FY2022.
- Gross Margin carries a five-year change of -20.34 percentage points (FY2018 to FY2023).
- Going back by year, Gross Margin was 80.98% in FY2022 (+8.60 pp), 72.38% in FY2021 (-23.14 pp), 95.52% in FY2020 (+3.91 pp) and 91.61% in FY2019 (+38.00 pp).
- The Q3 2024 figure represents the lowest quarterly Gross Margin in data going back to Q1 2017.
- Year-over-year, Gross Margin increased in three of the last six quarters, with an average year-over-year change of -10.66 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q4 2022 (a gain of 124.41 percentage points), and the weakest in Q4 2020 (a drop of 465.78 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -186.75% |
| Dec 31, 2023 | 138.70% |
| Sep 30, 2023 | -4.66% |
| Jun 30, 2023 | -10.11% |
| Mar 31, 2023 | -16.00% |
| Dec 31, 2022 | 30.80% |
| Sep 30, 2022 | 96.47% |
| Jun 30, 2022 | -51.69% |
| Mar 31, 2022 | 38.62% |
| Dec 31, 2021 | -93.61% |
| Sep 30, 2021 | 32.74% |
| Jun 30, 2021 | 97.53% |
| Mar 31, 2021 | 83.72% |
| Dec 31, 2020 | 94.72% |
| Sep 30, 2020 | 93.07% |
| Jun 30, 2020 | 94.17% |
| Mar 31, 2020 | 97.60% |
| Dec 31, 2019 | 560.50% |
| Sep 30, 2019 | 93.99% |
| Jun 30, 2019 | -6.91% |
API Access
Avalo Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();